Clonazepam
Klonopin
Ibogaine and Alprazolam
Also known as: Xanax
CNS depression + CYP3A4 substrate. Ibogaine enhances sedation. Short-acting — risk of rebound anxiety.
Severity
Major risk
Mechanism
Central nervous system depression
Protocol Status
Onsite supervised taper at MindScape
Restart Delay
Physician discretion
What "Major risk" Means
Serious clinical risk requiring physician-led tapering, washout, and monitoring. Treatment may proceed once the medication is appropriately cleared or transitioned.
Clinical Action
What our medical team does for patients on Alprazolam.
Onsite supervised taper at MindScape — patient arrives on prescribed benzodiazepine and the entire taper is conducted onsite under 24/7 physician supervision and telemetry, typically with crossover to diazepam and TA booster bridging. HCl flood dose deferred until titration to safe threshold.
Where the Washout Happens
Onsite supervised taper at MindScape
Patient arrives on the current prescribed dose. The entire taper is conducted onsite under continuous physician supervision and telemetry, supported by twice-daily ibogaine TA (total alkaloid) booster doses where indicated. The HCl flood dose is administered only after titration to the protocol-defined safe threshold.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
How Alprazolam interacts with ibogaine: central nervous system depression.
Sedatives — benzodiazepines, gabapentinoids, alcohol, sedating antihistamines, sleep aids — add to ibogaine's own sedation, ataxia, and respiratory effects. Concomitant CNS depressants are tapered before treatment and reintroduced cautiously after the active dosing window closes.
Same Mechanism
Other medications that interact via central nervous system depression.
Same Severity Tier
Other major risk medications (different mechanism).
Opioid receptor potentiation
Methadone
Methadose, Dolophine
Opioid receptor potentiation
Buprenorphine
Suboxone, Subutex
Opioid receptor potentiation
Fentanyl
Duragesic, Sublimaze
Opioid receptor potentiation
Oxycodone
Oxycontin, Percocet
Opioid receptor potentiation
Hydrocodone
Vicodin, Norco
Opioid receptor potentiation
Morphine
Ms Contin, Kadian
Common Questions
Alprazolam and ibogaine treatment.
Can I take ibogaine if I am on Alprazolam?
Major risk. CNS depression + CYP3A4 substrate. Ibogaine enhances sedation. Short-acting — risk of rebound anxiety. Onsite supervised taper at MindScape — patient arrives on prescribed benzodiazepine and the entire taper is conducted onsite under 24/7 physician supervision and telemetry, typically with crossover to diazepam and TA booster bridging. HCl flood dose deferred until titration to safe threshold.
How long do I need to be off Alprazolam before ibogaine treatment?
Onsite supervised taper at MindScape. Patient arrives on the current prescribed dose. The entire taper is conducted onsite under continuous physician supervision and telemetry, supported by twice-daily ibogaine TA (total alkaloid) booster doses where indicated. The HCl flood dose is administered only after titration to the protocol-defined safe threshold.
What is the mechanism of the interaction?
Central nervous system depression. Sedatives — benzodiazepines, gabapentinoids, alcohol, sedating antihistamines, sleep aids — add to ibogaine's own sedation, ataxia, and respiratory effects. Concomitant CNS depressants are tapered before treatment and reintroduced cautiously after the active dosing window closes.
Can I switch to a different medication so I can have ibogaine treatment?
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Alprazolam — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 103 medications in the A–Z directory.
DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 900 patients treated.
Last reviewed: May 2026 · See full medical team